Patient participation in medication reviews is desirable but not evidence-based: A systematic literature review

British Journal of Clinical Pharmacology

Volumn 78, Issue 6, 2014, Pages 1201-1216

  Willeboordse, Floor ^a,b   Hugtenburg, Jacqueline G ^a   Schellevis, François G ^a,b   Elders, Petra J M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

Author keywords

Drug related problems; Medication Reviews; Patient participation; Systematic literature review

Indexed keywords

ARTICLE; DRUG MONITORING; DRUG USE; EVIDENCE BASED PRACTICE; GENERAL PRACTITIONER; HOSPITAL ADMISSION; HUMAN; INTERPERSONAL COMMUNICATION; KNOWLEDGE; LABORATORY TEST; LIFESTYLE; MEDICAL HISTORY; MEDICAL INFORMATION; MEDICATION REVIEW; PATIENT ATTITUDE; PATIENT INFORMATION; PATIENT PARTICIPATION; PHARMACIST; POLYPHARMACY; PROFESSIONAL STANDARD; QUALITY CONTROL; QUALITY OF LIFE; RISK FACTOR; SOCIAL SUPPORT; SYSTEMATIC REVIEW; COUNSELING; DECISION MAKING; DRUG THERAPY; INFORMATION DISSEMINATION;

COUNSELING; DECISION MAKING; DRUG THERAPY; EVIDENCE-BASED PRACTICE; HUMANS; INFORMATION DISSEMINATION; PATIENT PARTICIPATION; QUALITY OF LIFE;

EID: 84918802155     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12398     Document Type: Article

References (65)

1. Longtin Y, Sax H, Leape LL, Sheridan SE, Donaldson L, Pittet D. Patient participation: current knowledge and applicability to patient safety. Mayo Clin Proc 2010; 85: 53-62.
2. World Health Organization (WHO). Patients for patients safety. Last update 2013. Available at http://www.who.int/patientsafety/patients-for-patient/en/(last accessed 19 April 2013).
3. Stevenson FA, Cox K, Britten N, Dundar Y. A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect 2004; 7: 235-45.
4. Geurts MM, Talsma J, Brouwers JR, de Gier JJ. Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. Br J Clin Pharmacol 2012; 74: 16-33.
5. Task Force on Medicines Partnership and The National Collaborative Medicines Management Services Programme. Room for Review: A Guide to Medication Review: the Agenda for Patients, Practitioners and Managers. London: Medicines Partnership, 2002.
6. Street RL Jr, Millay B. Analyzing patient participation in medical encounters. Health Commun 2001; 13: 61-73.
7. Thompson AG. The meaning of patient involvement and participation in health care consultations: a taxonomy. Soc Sci Med 2007; 64: 1297-310.
8. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med 1997; 44: 681-92.
9. Bezreh T, Laws MB, Taubin T, Rifkin DE, Wilson IB. Challenges to physician-patient communication about medication use: a window into the skeptical patient's world. Patient Prefer Adherence 2012; 6: 11-8.
10. Pharmaceutical Society of Australia Ltd. Guidelines for pharmacists providing Home Medicines Review (HMR) services. 2011.
11. Nederlands Huisarts Genootschap (NHG). Multidisciplinaire richtlijn Polyfarmacie bij ouderen. Utrecht, 2012.
12. Martinez LS, Schwartz JS, Freres D, Fraze T, Hornik RC. Patient-clinician information engagement increases treatment decision satisfaction among cancer patients through feeling of being informed. Patient Educ Couns 2009; 77: 384-90.
13. Wilson SR, Strub P, Buist AS, Knowles SB, Lavori PW, Lapidus J, Vollmer WM, the BOAT Study Group. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med 2010; 181: 566-77.
14. Greenfield S, Kaplan S, Ware JE Jr. Expanding patient involvement in care. Effects on patient outcomes. Ann Intern Med 1985; 102: 520-8.
15. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
16. Clyne W, Blenkinsopp A, Seal R, The National Prescribing Center. A guide to Medication Review. Medicines Partnership Programme. 2008.
17. Akazawa M, Nomura K, Kusama M, Igarashi A. Drug utilization reviews by community pharmacists in Japan: identification of potential safety concerns through the Brown Bag Program. Value Health Reg Issues 2012; 1: 98-104.
18. Chen J, Britten N. 'Strong medicine': an analysis of pharmacist consultations in primary care. Fam Pract 2000; 17: 480-3.
19. Elliott RA, Martinac G, Campbell S, Thorn J, Woodward MC. Pharmacist-led medication review to identify medication-related problems in older people referred to an Aged Care Assessment Team: a randomized comparative study. Drugs Aging 2012; 29: 593-605.
20. Gilbert AL, Roughead EE, Beilby J, Mott K, Barratt JD. Collaborative medication management services: improving patient care. Med J Aust 2002; 177: 189-92.
21. Granas AG, Berg C, Hjellvik V, Haukereid C, Kronstad A, Blix HS, Kilhovd B, Viktil KK, Horn AM. Evaluating categorisation and clinical relevance of drug-related problems in medication reviews. Pharm World Sci 2010; 32: 394-403.
22. Griffiths R, Johnson M, Piper M, Langdon R. A nursing intervention for the quality use of medicines by elderly community clients. Int J Nurs Pract 2004; 10: 166-76.
23. Grymonpre RE, Williamson DA, Montgomery PR. Impact of a pharmaceutical care model for non-instutionalised elderly: results of a randomised, controlled trial. Int J Pharm Pract 2001; 9: 235-41.
24. Hernandez MJ, Montero HM, Font NI, Domenech ML, Merino SV, Poveda Andres JL. Assessment of a reconciliation and information programme for heart transplant patients. Farm Hosp 2010; 34: 1-8.
25. Hugtenburg JG, Borgsteede SD, Beckeringh JJ. Medication review and patient counselling at discharge from the hospital by community pharmacists. Pharm World Sci 2009; 31: 630-7.
26. Jameson JP, VanNoord GR. Pharmacotherapy consultation on polypharmacy patients in ambulatory care. Ann Pharmacother 2001; 35: 835-40.
27. Karapinar-Carkit F, Borgsteede SD, Zoer J, Smit HJ, Egberts AC, van den Bemt PM. Effect of medication reconciliation with and without patient counseling on the number of pharmaceutical interventions among patients discharged from the hospital. Ann Pharmacother 2009; 43: 1001-10.
28. Kilcup M, Schultz D, Carlson J, Wilson B. Postdischarge pharmacist medication reconciliation: impact on readmission rates and financial savings. J Am Pharm Assoc (2003) 2013; 53: 78-84.
29. Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, Downie G, Seymour DG. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001; 30: 205-11.
30. Kwint HF, Faber A, Gussekloo J, Bouvy ML. The contribution of patient interviews to the identification of drug-related problems in home medication review. J Clin Pharm Ther 2012; 37: 674-80.
31. Lam A. Practice innovations: delivering medication therapy management services via videoconference interviews. Consult Pharm 2011; 26: 764-73.
32. Latif A, Pollock K, Boardman HF. The contribution of the Medicines Use Review (MUR) consultation to counseling practice in community pharmacies. Patient Educ Couns 2011; 83: 336-44.
33. Leendertse AJ, de Koning GH, Goudswaard AN, Belitser SV, Verhoef M, de Gier HJ, Egberts TCG, van den Bemt PMLA. Preventing hospital admissions by reviewing medication (PHARM) in primary care: an open controlled study in an elderly population. J Clin Pharm Ther 2013; 38: 379-87.
34. Moultry AM, Poon IO. Perceived value of a home-based medication therapy management program for the elderly. Consult Pharm 2008; 23: 877-85.
35. Nathan A, Goodyer L, Lovejoy A, Savage I. Patients' view of the value of 'brown bag' medication reviews. Int J Pharm Pract 2000; 8: 298-304.
36. Naunton M, Peterson GM. Evaluation of home-based follow-up of high-risk elderly patients discharged from hospital. J Pharm Pract Res 2003; 33: 176-82.
37. Nguyen A, Yu K, Shakib S, Doecke CJ, Boyce M, March G, Anderson BA, Gilbert AL, Angley MT. Classification of findings in the home medicines reviews of post-discharge patients at risk of medication misadventure. J Pharm Pract Res 2007; 37: 111-4.
38. Niquille A, Bugnon O. Relationship between drug-related problems and health outcomes: a cross-sectional study among cardiovascular patients. Pharm World Sci 2010; 32: 512-9.
39. Olsson IN, Runnamo R, Engfeldt P. Drug treatment in the elderly: an intervention in primary care to enhance prescription quality and quality of life. Scand J Prim Health Care 2012; 30: 3-9.
40. Petty DR, Knapp P, Raynor DK, House AO. Patients' views of a pharmacist-run medication review clinic in general practice. Br J Gen Pract 2003; 53: 607-13.
41. Pindolia VK, Stebelsky L, Romain TM, Luoma L, Nowak SN, Gillanders F. Mitigation of medication mishaps via medication therapy management. Ann Pharmacother 2009; 43: 611-20.
42. Salter C, Holland R, Harvey I, Henwood K. 'I haven't even phoned my doctor yet.' The advice giving role of the pharmacist during consultations for medication review with patients aged 80 or more: qualitative discourse analysis. BMJ 2007; 334: 1101-6.
43. Schneider J, Barber N. Provision of a domiciliary service by community pharmacists. Int J Pharm Pract 1996; 4: 19-24.
44. Sellors C, Dalby DM, Howard M, Kaczorowski J, Sellors J. A pharmacist consultation service in community-based family practices: a randomized, controlled trial in seniors. J Pharm Technol 2001; 17: 264-9.
45. Sheridan J, Butler R, Brandt T, Harrison J, Jensen M, Shaw J. Patients' and pharmacists' perceptions of a pilot Medicines Use Review service in Auckland, New Zealand. J Pharm Health Serv Res 2012; 3: 35-40.
46. Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Roberts MS. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol 2004; 58: 648-64.
47. Stewart AL, Lynch KJ. Identifying discrepancies in electronic medical records through pharmacist medication reconciliation. J Am Pharm Assoc (2003) 2012; 52: 59-66.
48. Swain LD. A pharmacist's contribution to an ambulatory neurology clinic. Consult Pharm 2012; 27: 49-57.
49. Viktil KK, Blix HS, Moger TA, Reikvam A. Interview of patients by pharmacists contributes significantly to the identification of drug-related problems (DRPs). Pharmacoepidemiol Drug Saf 2006; 15: 667-74.
50. Willoch K, Blix HS, Pedersen-Bjergaard AM, Eek AK, Reikvam A. Handling drug-related problems in rehabilitation patients: a randomized study. Int J Clin Pharm 2012; 34: 382-8.
51. Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001; 323: 1340-3.
52. Bissell P, Blenkinsopp A, Short D, Mason L. Patients' experiences of a community pharmacy-led medicines management service. Health Soc Care Community 2008; 16: 363-9.
53. The Community Pharmacy Medicines Management Project Evaluation Team. The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. Fam Pract 2007; 24: 189-200.
54. Kennedy JF. Special Message to the Congress on Protecting the Consumer Interest. 15-3-1962. Available at http://www .jfklink.com/speeches/jfk/publicpapers/1962/jfk93-62.html (last accessed 19 April 2013).
55. Guadagnoli E, Ward P. Patient participation in decision-making. Soc Sci Med 1998; 47: 329-39.
56. Wroe AL, Salkovskis PM, Rees M, Jack T. Information giving and involvement in treatment decisions: is more really better? Psychological effects and relation with adherence. Psychol Health 2013; 28: 954-71.
57. Singh JA, Sloan JA, Atherton PJ, Smith T, Hack TF, Huschka MM, Rummans TA, Clark MM, Diekmann B, Degner LF. Preferred roles in treatment decision making among patients with cancer: a pooled analysis of studies using the Control Preferences Scale. Am J Manag Care 2010; 16: 688-96.
58. Belcher VN, Fried TR, Agostini JV, Tinetti ME. Views of older adults on patient participation in medication-related decision making. J Gen Intern Med 2006; 21: 298-303.
59. Gibson PG, Talbot PI, Toneguzzi RC. Self-management, autonomy, and quality of life in asthma. Population Medicine Group 91C. Chest 1995; 107: 1003-8.
60. Hubbard G, Kidd L, Donaghy E. Preferences for involvement in treatment decision making of patients with cancer: a review of the literature. Eur J Oncol Nurs 2008; 12: 299-318.
61. Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM, Bero L. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev 2010; (7): CD000336.
62. Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med 1999; 49: 651-61.
63. Thomas BH, Ciliska D, Dobbins M, Micucci S. A process for systematically reviewing the literature: providing the research evidence for public health nursing interventions. Worldviews Evid Based Nurs 2004; 1: 176-84.
64. Armijo-Olivo S, Stiles CR, Hagen NA, Biondo PD, Cummings GG. Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: methodological research. J Eval Clin Pract 2012; 18: 12-8.
65. Critical Appraisal Skills Programme. CASP Critical appraisal checklists. Qualitative research checklist version 14-10-2010.